Results 101 to 110 of about 4,240,909 (230)

Prognostic and predictive value of CA19-9 in metastatic colorectal cancer.

open access: yes, 2013
354 Background: CA19-9 has been approved by FDA as a tumor marker in pancreatic cancer. The prognostic and predictive value of CA19-9 in metastatic colorectal cancer (mCRC) is still unclear.
Takashi Ura   +10 more
core   +1 more source

Localized Gastrointestinal Light Chain (AL) Amyloidosis Under Surveillance for Five Years: A Case Report

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Amyloidosis, characterized by the deposition of abnormal protein fibrils in organs, is classified as systemic or localized. Amyloid light chain (AL)‐type localized amyloidosis is uncommon, particularly when confined to the gastrointestinal tract.
Shunsuke Kojimahara   +7 more
wiley   +1 more source

Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2020
Yu-Cheng Cheng,1 Yu-Hsuan Li,1,2 Chiann-Yi Hsu,3 I-Te Lee1,4– 6 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; 2Graduate Institute of Data Science, Taipei Medical ...
Cheng YC, Li YH, Hsu CY, Lee IT
doaj  

CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer

open access: yesBMC Cancer, 2019
Background CA19–9 decrease during treatment has been associated with superior survival of pancreatic cancer in several studies. The evidence to show the correlation of high platelet level with inferior survival is insufficient in pancreatic cancer.
Y. Chen   +3 more
doaj   +1 more source

Optimal Stenting Strategy During Chemotherapy: Impact of Time to First Reintervention on Survival in Malignant Hilar Biliary Obstruction

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Advances in chemotherapy have increased survival in biliary tract cancer patients, and reports of the effectiveness of neoadjuvant therapy are emerging. Accordingly, developing optimal drainage strategies under chemotherapy is important.
Katsuhiko Sato   +8 more
wiley   +1 more source

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

open access: yesFrontiers in Oncology, 2019
Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use.
Ailing Zhong   +14 more
doaj   +1 more source

Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma

open access: yes
Background Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor with a poor prognosis, predominantly CA19-9 positive. High CA19-9 levels correlate with increased aggressiveness and worse outcomes.
Jie Gao   +12 more
core   +1 more source

CA19-9 serum levels predict micrometastases in patients with gastric cancer

open access: yes, 2016
Background. We explored the prognostic value of the up-regulated carbohydrate antigen (CA19-9) in node-negative patients with gastric cancer as a surrogate marker for micrometastases. Patients and methods.
Mojca Plankl   +9 more
core   +1 more source

Small‐Bowel Impaction Caused by Mechanical Interlocking Between Duodenal Metal and Biliary Plastic Stents

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Duodenal self‐expandable metal stents (SEMS) are widely used to treat malignant gastric outlet obstruction (GOO). However, stent migration is a well‐known complication. We report a rare case of small‐bowel impaction caused by the migration of a duodenal SEMS with a biliary plastic stent (PS).
Shinsuke Otagiri   +9 more
wiley   +1 more source

Methyliertes Septin 9 als Verlaufsparameter bei kolorektalen Karzinomen im Vergleich zu CEA und CA19-9

open access: yes, 2022
Einleitung: Methyliertes Septin 9 (mSEPT9) wurde als Verlaufsparameter bei kolorektalen Karzinomen mit CEA und CA19-9 verglichen. Methode: Prospektiv wurden 122 Patienten/innen mit kolorektalem Karzinom UICC-Stadium I-IV zur Resektion geplant und auf ...
Schulz, Laura
core  

Home - About - Disclaimer - Privacy